These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 15709170
21. Expression profiles of early esophageal squamous cell carcinoma by cDNA microarray. Zhang X, Lin P, Zhu ZH, Long H, Wen J, Yang H, Zhang X, Wang DF, Fu JH, Fang Y, Rong TH. Cancer Genet Cytogenet; 2009 Oct; 194(1):23-9. PubMed ID: 19737650 [Abstract] [Full Text] [Related]
22. Altered expression of ezrin in esophageal squamous cell carcinoma. Zeng H, Xu L, Xiao D, Zhang H, Wu X, Zheng R, Li Q, Niu Y, Shen Z, Li E. J Histochem Cytochem; 2006 Aug; 54(8):889-96. PubMed ID: 16585385 [Abstract] [Full Text] [Related]
23. Expression of RUNX3 protein in human esophageal mucosa and squamous cell carcinoma. Hiramatsu T, Osaki M, Ito Y, Tanji Y, Tokuyasu N, Ito H. Pathobiology; 2005 Aug; 72(6):316-24. PubMed ID: 16582583 [Abstract] [Full Text] [Related]
24. The role of mitochondrial DNA alterations in esophageal squamous cell carcinomas. Lin CS, Chang SC, Wang LS, Chou TY, Hsu WH, Wu YC, Wei YH. J Thorac Cardiovasc Surg; 2010 Jan; 139(1):189-197.e4. PubMed ID: 19660406 [Abstract] [Full Text] [Related]
25. A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients. Kurehara H, Ishiguro H, Kimura M, Mitsui A, Ando T, Sugito N, Mori R, Takashima N, Ogawa R, Fujii Y, Kuwabara Y. Int J Oncol; 2007 Feb; 30(2):421-8. PubMed ID: 17203224 [Abstract] [Full Text] [Related]
26. Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer. Terashita Y, Ishiguro H, Haruki N, Sugiura H, Tanaka T, Kimura M, Shinoda N, Kuwabara Y, Fujii Y. Oncol Rep; 2004 Oct; 12(4):827-31. PubMed ID: 15375507 [Abstract] [Full Text] [Related]
27. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma. Tachibana M, Tonomoto Y, Hyakudomi R, Hyakudomi M, Hattori S, Ueda S, Kinugasa S, Yoshimura H. Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172 [Abstract] [Full Text] [Related]
28. Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma. Kobayashi H, Ishii Y, Takayama T. J Surg Oncol; 2005 Jun 15; 90(4):233-8. PubMed ID: 15906366 [Abstract] [Full Text] [Related]
29. The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma. Okumura T, Tsunoda S, Mori Y, Ito T, Kikuchi K, Wang TC, Yasumoto S, Shimada Y. Clin Cancer Res; 2006 Sep 01; 12(17):5096-103. PubMed ID: 16951226 [Abstract] [Full Text] [Related]
30. Overexpression of the Wilms' tumor gene WT1 in esophageal cancer. Oji Y, Yano M, Nakano Y, Abeno S, Nakatsuka S, Ikeba A, Yasuda T, Fujiwara Y, Takiguchi S, Yamamoto H, Fujita S, Kanato K, Ito K, Jomgeow T, Kawakami M, Tsuboi A, Shirakata T, Nishida S, Hosen N, Oka Y, Aozasa K, Monden M, Sugiyama H. Anticancer Res; 2004 Sep 01; 24(5B):3103-8. PubMed ID: 15510596 [Abstract] [Full Text] [Related]
31. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Hu N, Flaig MJ, Su H, Shou JZ, Roth MJ, Li WJ, Wang C, Goldstein AM, Li G, Emmert-Buck MR, Taylor PR. Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6013-22. PubMed ID: 15447985 [Abstract] [Full Text] [Related]
32. Over-expression of gastrin-releasing peptide in human esophageal squamous cell carcinomas. Fang MZ, Liu C, Song Y, Yang GY, Nie Y, Liao J, Zhao X, Shimada Y, Wang LD, Yang CS. Carcinogenesis; 2004 Jun 15; 25(6):865-71. PubMed ID: 14764456 [Abstract] [Full Text] [Related]
33. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma. Xue LY, Hu N, Song YM, Zou SM, Shou JZ, Qian LX, Ren LQ, Lin DM, Tong T, He ZG, Zhan QM, Taylor PR, Lu N. BMC Cancer; 2006 Dec 22; 6():296. PubMed ID: 17187659 [Abstract] [Full Text] [Related]
34. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma. Gunduz E, Gunduz M, Beder L, Nagatsuka H, Fukushima K, Sutcu R, Delibas N, Yamanaka N, Shimizu K, Nagai N. Arch Otolaryngol Head Neck Surg; 2009 Mar 22; 135(3):254-60. PubMed ID: 19289703 [Abstract] [Full Text] [Related]
35. [Expression of nucleostemin mRNA and protein in the esophageal squamous cell carcinoma]. Zhang GY, Yin L, Li SL, Xing WY, Zhao QM, Le XP, Gao DL, Chen KS, Zhang YH, Zhang QX. Zhonghua Zhong Liu Za Zhi; 2008 Feb 22; 30(2):125-8. PubMed ID: 18646696 [Abstract] [Full Text] [Related]
36. Quantitative detection of TIMP-3 promoter hypermethylation and its prognostic significance in esophageal squamous cell carcinoma. Ninomiya I, Kawakami K, Fushida S, Fujimura T, Funaki H, Takamura H, Kitagawa H, Nakagawara H, Tajima H, Kayahara M, Ohta T. Oncol Rep; 2008 Dec 22; 20(6):1489-95. PubMed ID: 19020732 [Abstract] [Full Text] [Related]
37. Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal squamous cell carcinoma. Fatima S, Chui CH, Tang WK, Hui KS, Au HW, Li WY, Wong MM, Cheung F, Tsao SW, Lam KY, Beh PS, Wong J, Law S, Srivastava G, Ho KP, Chan AS, Tang JC. Int J Mol Med; 2006 Jan 22; 17(1):159-70. PubMed ID: 16328025 [Abstract] [Full Text] [Related]
38. MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia. Zambon A, Mandruzzato S, Parenti A, Macino B, Dalerba P, Ruol A, Merigliano S, Zaninotto G, Zanovello P. Cancer; 2001 May 15; 91(10):1882-8. PubMed ID: 11346870 [Abstract] [Full Text] [Related]